Merilee Raines
CIK 1023869 · Executive VP & CFO · last filed 2026-08-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IDXX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE IDEXX DRIVE
WESTBROOK, ME 04092
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WTS | Director | 21,670 | $353.30 | $7.66M | $0 | 17 | 2026-08-04 |
| OCUL | Director | 60,933 | $7.14 | $435.1K | $0 | 6 | 2026-06-12 |
| TMDX | Director | 6,981 | $72.75 | $507.9K | $0 | 7 | 2026-05-22 |
| BHE | Director | 24,489 | $65.26 | $1.60M | $0 | 3 | 2021-05-14 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 0 | — | — | $0 | 7 | 2019-07-18 |
| AFFYMETRIX INC (AFFX) Delisted | Director | 0 | — | — | $0 | 3 | 2016-04-01 |
| IDXX | Executive VP & CFO | 39,332 | $698.55 | $27.48M | -$38.68M | 25 | 2013-02-27 |
Recent Filings · Page 4 of 7
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-05 | WTS | Grant (A) | +1,837 | $0 | EDGAR |
| 2016-06-28 | ARATANA THERAPEUTICS, INC. (PETX) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2016-04-01 | AFFYMETRIX INC (AFFX) Delisted | Disp (D) | −7,579 | $0 | EDGAR |
| 2015-07-28 | WTS | Grant (A) | +1,728 | $0 | EDGAR |
| 2015-06-19 | ARATANA THERAPEUTICS, INC. (PETX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-15 | AFFYMETRIX INC (AFFX) Delisted | Grant (A) | +7,579 | $0 | EDGAR |
| 2015-01-14 | AFFYMETRIX INC (AFFX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-04 | WTS | Grant (A) | +1,751 | $0 | EDGAR |
| 2014-02-06 | ARATANA THERAPEUTICS, INC. (PETX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-08-06 | WTS | Grant (A) | +1,643 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.